Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro

Published:2017-04-07 Issue:24 Volume:8 Page:38568-38580
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Deng Cuimin¹,Xiong Jiani²,Gu Xiaofan¹,Chen Xiaoying³,Wu Shuifa⁴,Wang Zhe¹,Wang Duanduan⁵,Tu Jinjin¹,Xie Jieming¹

Affiliation:

1. Department of Pharmacology, Fujian Medical University, Fuzhou, Fujian, China

2. Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China

3. Department of Experimental Teaching Center of Basic Medical Science, Fujian Medical University, Fuzhou, Fujian, China

4. Department of Pharmacology, The 180th Hospital of PLA, Quanzhou, Fujian, China

5. Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-domain antibodies as therapeutics for solid tumor treatment;Acta Pharmaceutica Sinica B;2024-07

2. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies;Life Sciences;2024-05

3. Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review;Frontiers in Immunology;2024-04-17

4. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFRWT and EGFRT790M with ADMET Profiling;Bioorganic Chemistry;2024-02

5. 2‐Thioxo‐3,4‐dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFR^T790M and VEGFR‐2 inhibitors: Design, synthesis, docking, and anticancer evaluations;Drug Development Research;2024-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3